• English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • italiano 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Login
Mostra Item 
  •   DSpace Home
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Mostra Item
  •   DSpace Home
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Mostra Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
Tutto DSpace
  • Archivi & Collezioni
  • Data di pubblicazione
  • Autori
  • Titoli
  • Soggetti

Combination of rrt-pcr and anti-nucleocapsid/anti-spike antibodies to characterize specimens with very low viral sars-cov-2 load: A real-life experience

Thumbnail
Autore
Florou Z., Zigra M., Kartalidis P., Tsilipounidaki K., Papadamou G., Belia A., Fthenakis G.C., Petinaki E.
Data
2021
Language
en
DOI
10.3390/microorganisms9061263
Soggetto
MDPI AG
Mostra tutti i dati dell'item
Abstract
The objective of the present study was to evaluate the true positivity among people, whose results of initial testing of nasopharyngeal swabs (NPS) showed a very low viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Seventy-seven people detected with low viral loads of SARs-CoV-2 in nasopharyngeal samples (Ct ≥ 35) were enrolled in the study. For this purpose, a second NPS was collected for rRT-PCR (real-time reverse transcription polymerase chain reaction) combined with a pair of serum samples for detection of anti-nucleocapsid (anti-N) and anti-spike (anti-S) antibodies. In 8 people, subsequent examinations indicated an increase in viral loads, thereafter, followed by an increase of anti-N and anti-S antibodies, findings compatible with an early stage of COVID-19 infection. In 9 people, who already had increased anti-N antibodies, subsequent examination showed a decrease or absence of viral load and an increase in antibodies, indicative of a late stage of COVID-19 infection. In 60 people, subsequent examination showed absence of infection (as indicated by absence of viral load and antibodies). We propose that the combination of a second NPS and one serum-specimen, both taken three days after the first NPS, helps significantly to avoid false-positive results. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
URI
http://hdl.handle.net/11615/71626
Collections
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]
htmlmap 

 

Ricerca

Tutto DSpaceArchivi & CollezioniData di pubblicazioneAutoriTitoliSoggettiQuesta CollezioneData di pubblicazioneAutoriTitoliSoggetti

My Account

LoginRegistrazione
Help Contact
DepositionAboutHelpContattaci
Choose LanguageTutto DSpace
EnglishΕλληνικά
htmlmap